A mouse model of osteochondromagenesis from clonal inactivation of Ext1 in chondrocytes

We report a mouse model of multiple osteochondromas (MO), an autosomal dominant disease in humans, also known as multiple hereditary exostoses (MHE or HME) and characterized by the formation of cartilage-capped osseous growths projecting from the metaphyses of endochondral bones. The pathogenesis of these osteochondromas has remained unclear. Mice heterozygous for Ext1 or Ext2, modeling the human genotypes that cause MO, occasionally develop solitary osteochondroma-like structures on ribs [Lin et al. (2000) Dev Biol 224(2):299–311; Stickens et al. (2005) Development 132(22):5055–5068]. Rather than model the germ-line genotype, we modeled the chimeric tissue genotype of somatic loss of heterozygosity (LOH), by conditionally inactivating Ext1 via head-to-head loxP sites and temporally controlled Cre-recombinase in chondrocytes. These mice faithfully recapitulate the human phenotype of multiple metaphyseal osteochondromas. We also confirm homozygous disruption of Ext1 in osteochondroma chondrocytes and their origin in proliferating physeal chondrocytes. These results explain prior modeling failures with the necessity for somatic LOH in a developmentally regulated cell type.

[1]  M. Kmita,et al.  Recombination between inverted loxP sites is cytotoxic for proliferating cells and provides a simple tool for conditional cell ablation , 2008, Proceedings of the National Academy of Sciences.

[2]  C. Chien,et al.  Regulation of Zebrafish Skeletogenesis by ext2/dackel and papst1/pinscher , 2008, PLoS genetics.

[3]  M. Capecchi,et al.  Two cell lineages, myf5 and myf5-independent, participate in mouse skeletal myogenesis. , 2008, Developmental cell.

[4]  H. Kronenberg,et al.  A Novel Transgenic Mouse Model to Study the Osteoblast Lineage in Vivo , 2007, Annals of the New York Academy of Sciences.

[5]  A. Cleton-Jansen,et al.  The role of EXT1 in nonhereditary osteochondroma: identification of homozygous deletions. , 2007, Journal of the National Cancer Institute.

[6]  A. Cleton-Jansen,et al.  Decreased EXT expression and intracellular accumulation of heparan sulphate proteoglycan in osteochondromas and peripheral chondrosarcomas , 2007, The Journal of pathology.

[7]  P. Roughley,et al.  Generation of a transgenic mouse in which Cre recombinase is expressed under control of the type II collagen promoter and doxycycline administration. , 2006, Matrix biology : journal of the International Society for Matrix Biology.

[8]  Z. Werb,et al.  Mice deficient in Ext2 lack heparan sulfate and develop exostoses , 2005, Development.

[9]  A. Vortkamp,et al.  Ext1-dependent heparan sulfate regulates the range of Ihh signaling during endochondral ossification. , 2004, Developmental cell.

[10]  S. Selleck,et al.  Abrogation of heparan sulfate synthesis in Drosophila disrupts the Wingless, Hedgehog and Decapentaplegic signaling pathways , 2004, Development.

[11]  H. Kitagawa,et al.  Heparin and Heparan Sulfate Biosynthesis , 2002, IUBMB life.

[12]  W. Cole,et al.  Heparan sulfate abnormalities in exostosis growth plates. , 2002, Bone.

[13]  C. Tabin,et al.  Expression of Cre recombinase in the developing mouse limb bud driven by a Prxl enhancer , 2002, Genesis.

[14]  K. Hashimoto,et al.  Induced DNA recombination by Cre recombinase protein transduction , 2002, Genesis.

[15]  Shi Tang,et al.  A cre/loxP‐deleter transgenic line in mouse strain 129S1/SvImJ , 2002, Genesis.

[16]  A. McMahon,et al.  Genetic manipulation of hedgehog signaling in the endochondral skeleton reveals a direct role in the regulation of chondrocyte proliferation. , 2001, Development.

[17]  A. Bradley,et al.  Engineering chromosomal rearrangements in mice , 2001, Nature Reviews Genetics.

[18]  J. Esko,et al.  Etiological point mutations in the hereditary multiple exostoses gene EXT1: a functional analysis of heparan sulfate polymerase activity. , 2001, American journal of human genetics.

[19]  M. Lovett,et al.  Diminished levels of the putative tumor suppressor proteins EXT1 and EXT2 in exostosis chondrocytes. , 2001, Cell motility and the cytoskeleton.

[20]  H. Kitagawa,et al.  The EXT1/EXT2 tumor suppressors: catalytic activities and role in heparan sulfate biosynthesis , 2000, EMBO reports.

[21]  M. Matzuk,et al.  Disruption of gastrulation and heparan sulfate biosynthesis in EXT1-deficient mice. , 2000, Developmental biology.

[22]  D. Ovchinnikov,et al.  Col2a1‐directed expression of Cre recombinase in differentiating chondrocytes in transgenic mice , 2000, Genesis.

[23]  C. McCormick,et al.  The putative tumor suppressors EXT1 and EXT2 form a stable complex that accumulates in the Golgi apparatus and catalyzes the synthesis of heparan sulfate. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[24]  A. Cleton-Jansen,et al.  EXT-mutation analysis and loss of heterozygosity in sporadic and hereditary osteochondromas and secondary chondrosarcomas. , 1999, American journal of human genetics.

[25]  D. Porter,et al.  The neoplastic pathogenesis of solitary and multiple osteochondromas , 1999, The Journal of pathology.

[26]  C. Lobe,et al.  Z/AP, a double reporter for cre-mediated recombination. , 1999, Developmental biology.

[27]  N. Rifai,et al.  Late onset of renal and hepatic cysts in Pkd1-targeted heterozygotes , 1999, Nature Genetics.

[28]  K. Rajewsky,et al.  Rapid elimination of mature autoreactive B cells demonstrated by Cre-induced change in B cell antigen receptor specificity in vivo. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[29]  W. Klein,et al.  Expression and functional analysis of mouse EXT1, a homolog of the human multiple exostoses type 1 gene. , 1998, Biochemical and biophysical research communications.

[30]  G. Evans,et al.  Gene for multiple exostoses (EXT2) maps to 11(p11.2p12) and is deleted in patients with a contiguous gene syndrome. , 1998, American journal of medical genetics.

[31]  G. Mortier,et al.  Mutations in the EXT1 and EXT2 genes in hereditary multiple exostoses. , 1998, American journal of human genetics.

[32]  H. Höfler,et al.  Laser-assisted preparation of single cells from stained histological slides for gene analysis , 1997, Histochemistry and Cell Biology.

[33]  G. Martin,et al.  Cre–mediated chromosome loss in mice , 1997, Nature Genetics.

[34]  W. Chan,et al.  Clonality in nodular lymphocyte-predominant Hodgkin's disease. , 1997, The New England journal of medicine.

[35]  Clifford J. Tabin,et al.  Regulation of Rate of Cartilage Differentiation by Indian Hedgehog and PTH-Related Protein , 1996, Science.

[36]  M. Scott,et al.  Conservation of the hedgehog/patched signaling pathway from flies to mice: induction of a mouse patched gene by Hedgehog. , 1996, Genes & development.

[37]  A. McMahon,et al.  Hedgehog and Bmp genes are coexpressed at many diverse sites of cell-cell interaction in the mouse embryo. , 1995, Developmental biology.

[38]  M. Wagner,et al.  Cloning of the putative tumour suppressor gene for hereditary multiple exostoses (EXT1) , 1995, Nature Genetics.

[39]  L. Strong,et al.  Hereditary multiple exostosis and chondrosarcoma: linkage to chromosome II and loss of heterozygosity for EXT-linked markers on chromosomes II and 8. , 1995, American journal of human genetics.

[40]  R. Pauli,et al.  Natural history study of hereditary multiple exostoses. , 1995, American journal of medical genetics.

[41]  L. Donehower,et al.  Spontaneous and carcinogen–induced tumorigenesis in p53–deficient mice , 1993, Nature Genetics.

[42]  R. Paniagua,et al.  Osteochondroma induced by reflection of the perichondrial ring in young rat radii , 1987, Calcified Tissue International.

[43]  K. Kohno,et al.  Isolation and characterization of a cDNA clone for the amino-terminal portion of the pro-alpha 1(II) chain of cartilage collagen. , 1984, The Journal of biological chemistry.

[44]  A. Knudson Mutation and cancer: statistical study of retinoblastoma. , 1971, Proceedings of the National Academy of Sciences of the United States of America.

[45]  A. Winterpacht,et al.  Ucma--A novel secreted factor represents a highly specific marker for distal chondrocytes. , 2008, Matrix biology : journal of the International Society for Matrix Biology.

[46]  J. Bovée Orphanet Journal of Rare Diseases BioMed Central Review Multiple osteochondromas , 2008 .

[47]  M. Tada,et al.  Targeted chromosome elimination from ES-somatic hybrid cells , 2007, Nature Methods.

[48]  Philippe Soriano Generalized lacZ expression with the ROSA26 Cre reporter strain , 1999, Nature Genetics.

[49]  E. Wijsman,et al.  Evaluation of locus heterogeneity and EXT1 mutations in 34 families with hereditary multiple exostoses , 1998, Human mutation.

[50]  L. Strong,et al.  Hereditary multiple exostoses (EXT): mutational studies of familial EXT1 cases and EXT-associated malignancies. , 1997, American journal of human genetics.

[51]  B. Olsen,et al.  A dominant negative mutation in the alpha 1 (X) collagen gene produces spondylometaphyseal defects in mice. , 1993, Progress in clinical and biological research.